{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:17:51Z","timestamp":1768810671072,"version":"3.49.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007150","name":"United Therapeutics Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0205195","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T17:35:46Z","timestamp":1541093746000},"page":"e0205195","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells"],"prefix":"10.1371","volume":"13","author":[{"given":"Christopher","family":"Lambers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kornauth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicitas","family":"Oberndorfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7762-5477","authenticated-orcid":true,"given":"Panja M.","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8139-2821","authenticated-orcid":true,"given":"Michael","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"ref1","first-page":"1731","article-title":"The limits of oral therapy in pulmonary arterial hypertension management","volume":"11","author":"QQ Liu","year":"2015","journal-title":"Ther. Clin. Risk. Manag"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ccm.2013.08.009","article-title":"Pathology of pulmonary hypertension","volume":"34","author":"RM Tuder","year":"2013","journal-title":"Clin. Chest Med"},{"key":"ref3","article-title":"Efficacy and safety of PAH-specific therapy in pulmonary arterial hypertension: a meta-analysis of randomized clinical trials","author":"HL Liu","year":"2016","journal-title":"Chest"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1540\/jsmr.50.8","article-title":"Pathological function of Ca2+-sensing receptor in pulmonary arterial hypertension","volume":"50","author":"A Yamamura","year":"2014","journal-title":"J. Smooth Muscle Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.12-2875","article-title":"Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial","volume":"44","author":"VF Tapson","year":"2013","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/1873-3468.12038","article-title":"PDGF-dependent \u03b2-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension","volume":"590","author":"J Takahashi","year":"2016","journal-title":"FEBS Lett"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e100310","DOI":"10.1371\/journal.pone.0100310","article-title":"Key role of the endothelial TGF-\u03b2\/ALK1\/endoglin signaling pathway in humans and rodents pulmonary hypertension","volume":"9","author":"B Gore","year":"2014","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/CE.S50607","article-title":"Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review","volume":"9","author":"MS Buckley","year":"2014","journal-title":"Core Evid"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.healun.2011.03.011","article-title":"Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials","volume":"30","author":"RL Benza","year":"2011","journal-title":"J. Heart Lung Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40264-015-0365-x","article-title":"Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension","volume":"39","author":"C O'Connell","year":"2016","journal-title":"Drug Saf"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/FJC.0000000000000357","article-title":"Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension","volume":"67","author":"KS Parikh","year":"2016","journal-title":"J. Cardiovasc. Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/677360","article-title":"Safety and efficacy of transition from inhaled treprostinil to parenteral treprostinil in selected patients with pulmonary arterial hypertension","volume":"4","author":"IR Preston","year":"2014","journal-title":"Pulm. Circ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.bbrc.2007.06.135","article-title":"IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues","volume":"360","author":"E Falcetti","year":"2007","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/10739680701833804","article-title":"Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes","volume":"15","author":"RS Sprague","year":"2008","journal-title":"Microcirculation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1165\/rcmb.2010-0240OC","article-title":"Treprostinil inhibits the adhesion and differentiation of fibrocytes via the cyclic adenosine monophosphate-dependent and Ras-proximate protein-dependent inactivation of extracellular regulated kinase","volume":"45","author":"VS Nikam","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.healun.2009.09.005","article-title":"Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial","volume":"29","author":"J Hiremath","year":"2010","journal-title":"J. Heart Lung Transplant"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/rcmb.2012-0049OC","article-title":"Inhibition of overactive transforming growth factor-\u03b2 signaling by prostacyclin analogs in pulmonary arterial hypertension","volume":"48","author":"T Ogo","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jchf.2014.03.013","article-title":"Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension","volume":"2","author":"Z Safdar","year":"2014","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201409-1742OC","article-title":"Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension","volume":"191","author":"R Damico","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"ref20","first-page":"e903947","article-title":"PPAR\u03b4 agonist GW501516 inhibits PDGF-stimulated pulmonary arterial smooth muscle cell function related to pathological vascular remodeling","author":"G Liu","year":"2013","journal-title":"Biomed. Res. Int"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bcp.2014.07.026","article-title":"Extracellular matrix composition is modified by \u03b2\u2082-agonists through cAMP in COPD","volume":"91","author":"C Lambers","year":"2014","journal-title":"Biochem. Pharmacol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.phrs.2015.09.010","article-title":"Aclidinium bromide combined with formoterol inhibits remodeling parameters in lung epithelial cells through cAMP","volume":"102","author":"C Lambers","year":"2015","journal-title":"Pharmacol. Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1074\/jbc.274.2.1005","article-title":"Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells","volume":"274","author":"O Eickelberg","year":"1999","journal-title":"J. Biol. Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1096\/fj.01-0226com","article-title":"Interaction of C\/EBPalpha and the glucocorticoid receptor in vivo and in non-transformed human cells","volume":"16","author":"JJ R\u00fcdiger","year":"2002","journal-title":"FASEB J"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12020-009-9220-0","article-title":"Activation of TR4 orphan nuclear receptor gene promoter by cAMP\/PKA and C\/EBP signaling","volume":"36","author":"NC Liu","year":"2009","journal-title":"Endocrine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(02)11319-5","article-title":"Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling","volume":"360","author":"M Roth","year":"2002","journal-title":"Lancet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e73399","DOI":"10.1371\/journal.pone.0073399","article-title":"The interaction of endothelin-1 and TGF-\u03b21 mediates vascular cell remodeling","volume":"8","author":"C Lambers","year":"2013","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1165\/ajrcmb.26.2.4695","article-title":"Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery","volume":"26","author":"LH Clapp","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.201001-0011OC","article-title":"Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension","volume":"182","author":"E Falcetti","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/ATVBAHA.115.307011","article-title":"Induction of Angiogenesis by a Type III Phosphodiesterase Inhibitor, Cilostazol, Through Activation of Peroxisome Proliferator-Activated Receptor-\u03b3 and cAMP Pathways in Vascular Cells","volume":"36","author":"F Sanada","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/CIRCULATIONAHA.114.009751","article-title":"Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension","volume":"130","author":"KJ Bubb","year":"2014","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/CIRCRESAHA.109.209940","article-title":"Smad-dependent and smad-independent induction of id1 by prostacyclin analogues inhibits proliferation of pulmonary artery smooth muscle cells in vitro and in vivo","volume":"107","author":"J Yang","year":"2010","journal-title":"Circ. Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa021660","article-title":"Dysfunctional interaction of C\/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells","volume":"351","author":"M Roth","year":"2004","journal-title":"N. Engl. J. Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1183\/09031936.00068010","article-title":"House dust mite extract downregulates C\/EBP\u03b1 in asthmatic bronchial smooth muscle cells","volume":"38","author":"N Miglino","year":"2011","journal-title":"Eur. Respir. J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/leu.2015.324","article-title":"The multifaceted functions of C\/EBP\u03b1 in normal and malignant haematopoiesis","volume":"30","author":"E Ohlsson","year":"2016","journal-title":"Leukemia"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.plefa.2005.04.004","article-title":"The transcriptional basis of adipocyte development","volume":"73","author":"ED Rosen","year":"2005","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e78569","DOI":"10.1371\/journal.pone.0078569","article-title":"Changes in large pulmonary arterial viscoelasticity in chronic pulmonary hypertension","volume":"8","author":"Z Wang","year":"2013","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12815","article-title":"Limiting collagen turnover via collagenase-resistance attenuates right ventricular dysfunction and fibrosis in pulmonary arterial hypertension","volume":"4","author":"MJ Golob","year":"2016","journal-title":"Physiol. Rep"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.thromres.2014.05.005","article-title":"Effects of peroxisome proliferator-activated receptor \u03b3 in simvastatin antiplatelet activity: influences on cAMP and mitogen-activated protein kinases","volume":"34","author":"H Du","year":"2014","journal-title":"Thromb. Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1183\/09031936.00188013","article-title":"Iloprost reverses established fibrosis in experimental right ventricular failure","volume":"45","author":"J Gomez-Arroyo","year":"2015","journal-title":"Eur. Respir. J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0205195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T15:54:40Z","timestamp":1589039680000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0205195"}},"subtitle":[],"editor":[{"given":"Gianfranco","family":"Pintus","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0205195","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}